Galaz-Sánchez MG, Olivas-Peñuñuri MR

Language: Spanish
References: 17
Page: 15-21
PDF size: 44.92 Kb.

ABSTRACT

The metabolic syndrome (MS), represented by a set of risk factors that are associated with increased cardiovascular morbidity.
Objective: To identify risk factors cardiovascular associated with MS, students from the Bachelor of Nursing at the University of Sonora.
Methods: We evaluated 100 students: anthropometry: Weight, height, BMI, waist circumference; clinic: Blood pressure and biochemistry: Basal glucose levels, lipid profile.
Results: 48% had diagnosis of MS, the average age: 22 years, with a BMI of 31 (Kg./m²) for volunteers who had MS and 23 (Kg./m²) for those who did not have this diagnostic criteria. Total cholesterol and fasting glucose levels were higher in subjects with MS (p‹0.04, p‹0.02, p‹0.02 respectively), whereas c-HDL was lower (p‹0.02). When adjusted for variables: age, sex, BMI, abdominal fat only HDL-c remains significant (p‹0.02). Systolic pressure and diastolic blood pressures were higher in young people with MS with p‹0.0001, p‹0.02, respectively. Of these indicators only systolic pressure (p‹0.04) remained significant after adjustment for confounding variables themselves. Markers that showed metabolic changes in participants with MS are total cholesterol, triglycerides, fasting glucose with 18(38%) 15(31%) 17(35%) respectively.
Conclusions: The significance of this study lies in the fact that young people were identified with MS. Alterations initials of each of these risk factors can occur in associations and even for discrete variables that alterations were recorded, representing an adverse cardiovascular profile. The detected cases were referred to a health clinic to clinic and to a nutrition clinic at the University of Sonora for monitoring, control and treatment.

REFERENCES

1. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.

2. ADA. The Expert Committee on the Diagnosis and classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26(1): S5-20.

3. Warnick GR, Alberts J. Heparin-Mn2 Quantization of high density lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. J Clin Chem Biochem 1978; 24: 900-4.

4. Wahlefeld A, Bergmeyer H. Methoden der Enzymatischen Analyse. 3a. Edición. Tomo II. Verlag Chemir, Weinheim. pp. 1878.

5. Friedwald WT, Kevy RI, Fredrikson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. J Clin Chem Biochem 1972; 18: 499-502.

6. Grundy SM; Balady GJ; Cliqui MH y col. Primary Prevention of Coronary Heart Disease: Guidance From Framinghan. A Statement of Healthkare Professionals from the AHA Task Force on Risk Reduction. Circulation 1998; 97: 1876: 1887.

7. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final Report. Circulation. 2002; 106: 3143-421.

8. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factors categories. Circulation. 1998; 97: 1837-47.

9. Bao W, Srinivisan S, Wattigney W, Berenson GS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood: The Bogalusa Heart Study. Arch Intern Med. 1994; 154: 1842-7.

10. Berenson G, Wattigney W, Tracy R, Bao W, Srinivisan SR, Newman III WP. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (the Bogalusa Heart Study). Am J Cardiol. 1992; 70: 851-8.

11. Kavey RW, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association Guidelines for primary prevention of atherosclerotic. cardiovascular disease beginning childhood. Circulation. 2003; 107: 1562-6.

12. Sotelo-Cruz N, Vázquez-Pizaña E, Ferra-Fragoso S, Encinas-Peñuñuri F. Factores de riesgo coronário en adolescentes sanos y obesos. Bol Med Hosp Infant Mex. Diciembre, 2001; 58: 828-42.

13. Sotelo-Cruz N, Vázquez-Pizaña E, Alcaraz-Ortega V, González-Olivos A, Reyes JG, Chávez E. Evaluación Clínica inicial en adolescentes con énfasis en la búsqueda de deficiencia de hierro e hipercolesterolemia. Bol Med Hosp Infant Mex, 1998; 55: 323-30.

14. Berenson GS, Srinivisan SR, Bao W, Newman III WP, Tracy RE, Wattigney WA, for the Bogalusa Heart Study. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med. 1998; 338: 650-6.

15. Braguinsky J.; Marin Per; Mollerach M. en Obesidad obdominovisceral Cap.8 pp 139. Obesidad, patogenia clínica y tratamiento. Braguinsky J y Col. Editorial El Ateneo, 2ª Edición 1999.

16. Rodríguez Porta AL; Sánchez León M; Martínez Valdez L. Síndrome Metabólico. Enfoque actual, Rev. Cubana Endocrinol. 2002; 13(3).

17. Steimberger J;Stephen RD. Obesity, Insulin Resistence, Diabetes, and Cardiovascular Risk in Children. Circulation 2003; 107: 1448.